Market
Vivani strikes reverse-merger agreement with ClearOne for BCI business
Vivani Medical has entered a reverse-merger agreement with ClearOne, combining its brain-computer interface (BCI) business with ClearOne to create a publicly listed entity. Upon completion, the combined company will be renamed Cortigent Holdings and will trade on Nasdaq, providing Vivani's BCI technology with public market access.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network